![](/img/cover-not-exists.png)
2111 A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)
Li, J., Xu, R., Bai, Y., Xu, J., Liu, T., Shen, L., Wang, L., Pan, H., Fan, S., Hua, Y., Su, W., Hugg, C.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31033-4
Date:
September, 2015
File:
PDF, 59 KB
english, 2015